Merck’s Keytruda Faces a Patent Cliff. These New Cancer Drugs Could Take Over.
Many think the next standard cancer treatment will pair two innovations.
The Associated Press
FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
The Food and Drug Administration has approved a first-of-its-kind pill that can drastically reduce cholesterol in a way that's previously only been ...
What Comes After Merck’s Keytruda? The Race for the Next Standard Cancer Treatment.
Many think the next standard cancer treatment will pair two innovations: antibody-drug conjugates, or ADCs, and augmented ...